CHO Pharma, Inc. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced operating loss was TWD 172.987 million compared to TWD 143.915 million a year ago. Net loss was TWD 166.978 million compared to TWD 136.934 million a year ago. Basic loss per share was TWD 0.91 compared to TWD 0.76 a year ago.